Intravenous immunoglobulin (also referred to as IVIG) is a product made up of antibodies that can be given intravenously. According to the American College of Rheumatology, it is prepared from a pool of immunoglobulins (antibodies) from the plasma of thousands of healthy donors.
Immunoglobulins are made by the immune system of healthy people to fight infections. While IVIG is derived from plasma (a blood product), it is so purified that the chances of contracting a blood-borne infection are extremely low.
Traditionally, IVIG has been used as replacement therapy for patients with primary or secondary immunoglobulin deficiencies.
DelveInsight’s “Intravenous Immunoglobulin Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Intravenous Immunoglobulin , historical and forecasted epidemiology as well as the Intravenous Immunoglobulin market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some facts of Intravenous Immunoglobulin Market:
Request for free Sample: https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market
Scope of the Intravenous Immunoglobulin Report:
Some of Intravenous Immunoglobulin Companies are:
Some of Intravenous Immunoglobulin Drugs are:
At present the market is currently dominated by the some of the key players, which includes Takeda (Baxter), Bio Products Laboratory, Grifols, CSL Behring, Octapharma, Kedrion Biopharma, and others.
Table of Contents:
1. Key Insights
2. Executive Summary of Intravenous Immunoglobulin
3. Competitive Intelligence Analysis for Intravenous Immunoglobulin
4. Intravenous Immunoglobulin : Market Overview at a Glance
5. Intravenous Immunoglobulin : Disease Background and Overview
6. Patient Journey
7. Intravenous Immunoglobulin Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Intravenous Immunoglobulin Treatment
11. Marketed Products
List to be continued in report
12. Emerging Therapies
13. Intravenous Immunoglobulin : Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Intravenous Immunoglobulin
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Request for Deatiled TOC: https://www.delveinsight.com/sample-request/intravenous-immunoglobulin-market
About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/intravenous-immunoglobulin-market